Buckingham Capital Management (Ohio)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Buckingham Capital Management (Ohio)'s BIIB Position: Q1 2019 in Review
Buckingham Capital Management (Ohio) sold out of Biogen (BIIB) in Q1 2019, closing a stake of 3,891 shares — an estimated $1.17M sold.
Buckingham Capital Management (Ohio) first reported a position in BIIB in Q1 2015 and held it in 16 quarters. The position peaked at $1.39M in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Buckingham Capital Management (Ohio) reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Buckingham Capital Management (Ohio) sold 3,891 Biogen shares in Q1 2019, an estimated $1.17M.
- Buckingham Capital Management (Ohio) first reported a position in Biogen in Q1 2015 and held it in 16 quarters.
- Buckingham Capital Management (Ohio)'s Biogen position peaked at $1.39M in Q3 2018.
- 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Buckingham Capital Management (Ohio)'s 13F filing for Q1 2019, filed 7 May 2019.